Adipocyte G
Adipocytes
/ cytology
Animals
Blood Glucose
/ metabolism
Diabetes Mellitus, Type 2
/ blood
GTP-Binding Protein alpha Subunits, Gi-Go
/ genetics
Gene Expression Profiling
/ methods
Glucose Intolerance
/ genetics
Homeostasis
/ genetics
Insulin
/ blood
Insulin Resistance
/ genetics
Male
Mice, Inbred C57BL
Mice, Knockout
Mice, Transgenic
Obesity
/ blood
Signal Transduction
/ genetics
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
12 06 2020
12 06 2020
Historique:
received:
02
09
2019
accepted:
18
05
2020
entrez:
14
6
2020
pubmed:
14
6
2020
medline:
25
8
2020
Statut:
epublish
Résumé
Adipocyte dysfunction links obesity to insulin resistance and type 2 diabetes. Adipocyte function is regulated by receptor-mediated activation of heterotrimeric G proteins. Little is known about the potential in vivo metabolic roles of G
Identifiants
pubmed: 32532984
doi: 10.1038/s41467-020-16756-x
pii: 10.1038/s41467-020-16756-x
pmc: PMC7293267
doi:
Substances chimiques
Blood Glucose
0
Insulin
0
GTP-Binding Protein alpha Subunits, Gi-Go
EC 3.6.5.1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2995Références
Guilherme, A., Virbasius, J. V., Puri, V. & Czech, M. P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9, 367–377 (2008).
pubmed: 18401346
pmcid: 2886982
doi: 10.1038/nrm2391
Gonzalez-Muniesa, P. et al. Obesity. Nat. Rev. Dis. Prim. 3, 17034 (2017).
pubmed: 28617414
doi: 10.1038/nrdp.2017.34
Kusminski, C. M., Bickel, P. E. & Scherer, P. E. Targeting adipose tissue in the treatment of obesity-associated diabetes. Nat. Rev. Drug Disco. 15, 639–660 (2016).
doi: 10.1038/nrd.2016.75
Saltiel, A. R. & Olefsky, J. M. Inflammatory mechanisms linking obesity and metabolic disease. J. Clin. Invest 127, 1–4 (2017).
pubmed: 28045402
pmcid: 5199709
doi: 10.1172/JCI92035
Guh, D. P. et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC public health 9, 88 (2009).
pubmed: 19320986
pmcid: 2667420
doi: 10.1186/1471-2458-9-88
Amisten, S. et al. An atlas of G-protein coupled receptor expression and function in human subcutaneous adipose tissue. Pharm. Ther. 146, 61–93 (2015).
doi: 10.1016/j.pharmthera.2014.09.007
Regard, J. B., Sato, I. T. & Coughlin, S. R. Anatomical profiling of G protein-coupled receptor expression. Cell 135, 561–571 (2008).
pubmed: 18984166
pmcid: 2590943
doi: 10.1016/j.cell.2008.08.040
Ghorbani, M. & Himms-Hagen, J. Appearance of brown adipocytes in white adipose tissue during CL 316,243-induced reversal of obesity and diabetes in Zucker fa/fa rats. Int. J. Obes. Relat. Metab. Disord.: J. Int. Assoc. Study Obes. 21, 465–475 (1997).
doi: 10.1038/sj.ijo.0800432
Xiao, C., Goldgof, M., Gavrilova, O. & Reitman, M. L. Anti-obesity and metabolic efficacy of the beta3-adrenergic agonist, CL316243, in mice at thermoneutrality compared to 22 degrees C. Obes. (Silver Spring, Md.) 23, 1450–1459 (2015).
doi: 10.1002/oby.21124
Himms-Hagen, J. et al. Effect of CL-316,243, a thermogenic beta 3-agonist, on energy balance and brown and white adipose tissues in rats. Am. J. Physiol. 266, R1371–R1382 (1994).
pubmed: 7910436
Collins, S. & Surwit, R. S. The beta-adrenergic receptors and the control of adipose tissue metabolism and thermogenesis. Recent Prog. Horm. Res. 56, 309–328 (2001).
pubmed: 11237219
doi: 10.1210/rp.56.1.309
Wang, L. et al. Selective activation of Gs signaling in adipocytes causes striking metabolic improvements in mice. Mol. Metab. https://doi.org/10.1016/j.molmet.2019.06.018 (2019).
Caron, A. et al. Adipocyte Gs but not Gi signaling regulates whole-body glucose homeostasis. Mol. Metab. https://doi.org/10.1016/j.molmet.2019.06.019 (2019).
Ruiz de Azua, I. et al. Adipocyte cannabinoid receptor CB1 regulates energy homeostasis and alternatively activated macrophages. J. Clin. Invest 127, 4148–4162 (2017).
pubmed: 29035280
pmcid: 5663356
doi: 10.1172/JCI83626
Offermanns, S. Free fatty acid (FFA) and hydroxy carboxylic acid (HCA) receptors. Annu Rev. Pharm. Toxicol. 54, 407–434 (2014).
doi: 10.1146/annurev-pharmtox-011613-135945
Lukasova, M., Hanson, J., Tunaru, S. & Offermanns, S. Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials. Trends Pharm. Sci. 32, 700–707 (2011).
pubmed: 21944259
doi: 10.1016/j.tips.2011.08.002
Wettschureck, N. & Offermanns, S. Mammalian G proteins and their cell type specific functions. Physiological Rev. 85, 1159–1204 (2005).
doi: 10.1152/physrev.00003.2005
Armbruster, B. N., Li, X., Pausch, M. H., Herlitze, S. & Roth, B. L. Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Proc. Natl Acad. Sci. USA 104, 5163–5168 (2007).
pubmed: 17360345
doi: 10.1073/pnas.0700293104
Rogan, S. C. & Roth, B. L. Remote control of neuronal signaling. Pharm. Rev. 63, 291–315 (2011).
pubmed: 21415127
doi: 10.1124/pr.110.003020
Eguchi, J. et al. Transcriptional control of adipose lipid handling by IRF4. Cell Metab. 13, 249–259 (2011).
pubmed: 21356515
pmcid: 3063358
doi: 10.1016/j.cmet.2011.02.005
Regard, J. B. et al. Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. J. Clin. Invest 117, 4034–4043 (2007).
pubmed: 17992256
pmcid: 2066199
Kraemer, F. B. & Shen, W. J. Hormone-sensitive lipase: control of intracellular tri-(di-)acylglycerol and cholesteryl ester hydrolysis. J. Lipid Res 43, 1585–1594 (2002).
pubmed: 12364542
doi: 10.1194/jlr.R200009-JLR200
Cerk, I. K., Wechselberger, L. & Oberer, M. Adipose triglyceride lipase regulation: an overview. Curr. Protein Pept. Sci. 19, 221–233 (2018).
pubmed: 28925902
Ayala, J. E. et al. Hyperinsulinemic-euglycemic clamps in conscious, unrestrained mice. J. Vis. Exp. https://doi.org/10.3791/3188 (2011).
Boden, G. Obesity and free fatty acids. Endocrinol. Metab. Clin. North Am. https://doi.org/10.1016/j.ecl.2008.06.007 (2008).
Girousse, A. et al. Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass. PLoS Biol. 11, e1001485 (2013).
pubmed: 23431266
pmcid: 3576369
doi: 10.1371/journal.pbio.1001485
Claus, T. H. et al. Specific inhibition of hormone-sensitive lipase improves lipid profile while reducing plasma glucose. J. Pharmacol. Exp. therapeutics 315, 1396–1402 (2005).
doi: 10.1124/jpet.105.086926
Kwon, H. & Pessin, J. E. Adipokines mediate inflammation and insulin resistance. Front Endocrinol. (Lausanne) 4, 71 (2013).
doi: 10.3389/fendo.2013.00071
Jung, U. J. & Choi, M. S. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J. Mol. Sci. 15, 6184–6223 (2014).
pubmed: 24733068
pmcid: 4013623
doi: 10.3390/ijms15046184
Lumeng, C. N. & Saltiel, A. R. Inflammatory links between obesity and metabolic disease. J. Clin. Invest. 121, 2111–2117 (2011).
pubmed: 21633179
pmcid: 3104776
doi: 10.1172/JCI57132
Reilly, S. M. & Saltiel, A. R. Adapting to obesity with adipose tissue inflammation. Nat. Rev. Endocrinol. 13, 633–643 (2017).
pubmed: 28799554
doi: 10.1038/nrendo.2017.90
Dalle, S., Ricketts, W., Imamura, T., Vollenweider, P. & Olefsky, J. M. Insulin and insulin-like growth factor I receptors utilize different G protein signaling components. J. Biol. Chem. 276, 15688–15695 (2001).
pubmed: 11278773
doi: 10.1074/jbc.M010884200
Kreuzer, J., Nurnberg, B. & Krieger-Brauer, H. I. Ligand-dependent autophosphorylation of the insulin receptor is positively regulated by Gi-proteins. Biochem. J. 380, 831–836 (2004).
pubmed: 15025562
pmcid: 1224225
doi: 10.1042/bj20031659
Rozengurt, E., Sinnett-Smith, J. & Kisfalvi, K. Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer. Clin. Cancer Res. 16, 2505–2511 (2010).
pubmed: 20388847
pmcid: 2862089
doi: 10.1158/1078-0432.CCR-09-2229
Xu, E., Schwab, M. & Marette, A. Role of protein tyrosine phosphatases in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance. Rev. Endocr. Metab. Disord. 15, 79–97 (2014).
pubmed: 24264858
doi: 10.1007/s11154-013-9282-4
Owen, C. et al. Adipocyte-specific protein tyrosine phosphatase 1B deletion increases lipogenesis, adipocyte cell size and is a minor regulator of glucose homeostasis. PLoS ONE 7, e32700 (2012).
pubmed: 22389718
pmcid: 3289674
doi: 10.1371/journal.pone.0032700
Xie, L. et al. Cellular effects of small molecule PTP1B inhibitors on insulin signaling. Biochemistry 42, 12792–12804 (2003).
pubmed: 14596593
doi: 10.1021/bi035238p
Zhang, S. & Zhang, Z. Y. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery. Drug Disco. Today 12, 373–381 (2007).
doi: 10.1016/j.drudis.2007.03.011
Tao, J., Malbon, C. C. & Wang, H. Y. Insulin stimulates tyrosine phosphorylation and inactivation of protein-tyrosine phosphatase 1B in vivo. J. Biol. Chem. 276, 29520–29525 (2001).
pubmed: 11395511
doi: 10.1074/jbc.M103721200
Brautigan, D. L. & Pinault, F. M. Activation of membrane protein-tyrosine phosphatase involving cAMP- and Ca2+/phospholipid-dependent protein kinases. Proc. Natl Acad. Sci. USA 88, 6696–6700 (1991).
pubmed: 1650478
doi: 10.1073/pnas.88.15.6696
Krishnan, N. et al. PTP1B inhibition suggests a therapeutic strategy for Rett syndrome. J. Clin. Invest 125, 3163–3177 (2015).
pubmed: 26214522
pmcid: 4563751
doi: 10.1172/JCI80323
Zhu, H. et al. Cre-dependent DREADD (designer receptors exclusively activated by designer drugs) mice. Genes 54, 439–446 (2016).
doi: 10.1002/dvg.22949
Rossi, M. et al. Hepatic Gi signaling regulates whole-body glucose homeostasis. J. Clin. Invest 128, 746–759 (2018).
pubmed: 29337301
pmcid: 5785257
doi: 10.1172/JCI94505
Mottillo, E. P., Shen, X. J. & Granneman, J. G. Role of hormone-sensitive lipase in beta-adrenergic remodeling of white adipose tissue. Am. J. Physiol. Endocrinol. Metab. 293, E1188–E1197 (2007).
pubmed: 17711991
doi: 10.1152/ajpendo.00051.2007
Berglund, E. D. et al. Glucose metabolism in vivo in four commonly used inbred mouse strains. Diabetes 57, 1790–1799 (2008).
pubmed: 18398139
pmcid: 2453626
doi: 10.2337/db07-1615
Ayala, J. E., Bracy, D. P., McGuinness, O. P. & Wasserman, D. H. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes 55, 390–397 (2006).
pubmed: 16443772
doi: 10.2337/diabetes.55.02.06.db05-0686
Finegood, D. T., Bergman, R. N. & Vranic, M. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36, 914–924 (1987).
pubmed: 3297886
doi: 10.2337/diab.36.8.914
Steele, R., Wall, J. S., De Bodo, R. C. & Altszuler, N. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am. J. Physiol. 187, 15–24 (1956).
pubmed: 13362583
doi: 10.1152/ajplegacy.1956.187.1.15
Gautam, D. et al. Beneficial metabolic effects of M3 muscarinic acetylcholine receptor deficiency. Cell Metab. 4, 363–375 (2006).
pubmed: 17084710
doi: 10.1016/j.cmet.2006.09.008
Tanaka, N. et al. Adipocyte-specific disruption of fat-specific protein 27 causes hepatosteatosis and insulin resistance in high-fat diet-fed mice. J. Biol. Chem. 290, 3092–3105 (2015).
pubmed: 25477509
doi: 10.1074/jbc.M114.605980
Kazak, L. et al. A creatine-driven substrate cycle enhances energy expenditure and thermogenesis in beige fat. Cell 163, 643–655 (2015).
pubmed: 26496606
pmcid: 4656041
doi: 10.1016/j.cell.2015.09.035
Nakajima, K. & Wess, J. Design and functional characterization of a novel, arrestin-biased designer G protein-coupled receptor. Mol. Pharm. 82, 575–582 (2012).
doi: 10.1124/mol.112.080358
Kim, J. K., Gavrilova, O., Chen, Y., Reitman, M. L. & Shulman, G. I. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J. Biol. Chem. 275, 8456–8460 (2000).
pubmed: 10722680
doi: 10.1074/jbc.275.12.8456